The GMZ2 malaria vaccine: from concept to efficacy in humans
Introduction: GMZ2 is a recombinant protein consisting of conserved domains of GLURP and MSP3, two asexual blood-stage antigens of Plasmodium falciparum, and is designed with the aim of mimicking naturally acquired anti-malarial immunity. The rationale for combining these two antigens is based on a...
Saved in:
Main Authors: | Michael Theisen (Author), Bright Adu (Author), Benjamin Mordmüller (Author), Subhash Singh (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2.
by: Odilon Nouatin, et al.
Published: (2021) -
The RTS,S malaria vaccine: Journey from conception to recommendation
by: Oluwaseyi Muyiwa Egbewande
Published: (2022) -
Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine
by: Michael Theisen, et al.
Published: (2017) -
Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human
by: Louis-Antoine Barel, et al.
Published: (2019) -
Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
by: Griffin J. Bell, et al.
Published: (2020)